Companies Creating New Kids' Medicines
From UPI Science News (March 30, 2010)
U.S. pharmaceutical companies released a report Tuesday, saying they are currently developing 234 medicines for the special healthcare needs of children.
The report from the trade group PhRMA, the Pharmaceutical Research and Manufacturers of America, was unveiled at Trinity Medical Center in Moline, Ill.
"Our researchers, who lead the world in pharmaceutical innovation, are working on new treatments to fight a wide range of major diseases and medical disorders that afflict children all over America," said PhRMA President Billy Tauzin. "Our companies’ targets include childhood cancer, the leading cause of death among Americans between the ages of 5 and 24, and an array of genetic disorders, including cystic fibrosis, a debilitating and fatal condition that affects 30,000 children and adults in the United States."
PhRMA says it "represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier and more productive lives."
Posted: March 2010